A

ASCIL Biopharm

22 employees

ASCIL Biopharm is a drug-delivery company developing proprietary miniaturized injectable and locally acting therapeutics.

Investor insights

Sectors invested in

Computer-aided drug design1
Peptides and peptidomimetics1
Protein-Protein interactions1
Innovation Management1
Drug development1
Biotechnology1
Chemical1

Funding rounds participated in

$1.6M sweet spot round size

Most of their 1 investments are in rounds between $1.6M and $1.6M

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Medtech
Health Care
Parenteral
Pharmaceuticals
Drug Delivery Systems

Date founded

2012

Investments made

I

Iproteos raised $1.6M on October 25, 2016

Investors: Kinled Holding Ltd and ASCIL Biopharm

FAQ